Icon plc Stock
Price
Target price
€288.50
€288.50
0.760%
2.2
0.760%
€326.21
22.08.24 / Tradegate
WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Icon plc Stock
Icon plc gained 0.760% compared to yesterday.
The stock is an absolute favorite of our community with 24 Buy predictions and no Sell predictions.
As a result the target price of 326 € shows a slightly positive potential of 13.0% compared to the current price of 288.5 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 0.760% | -1.536% | -5.781% | 24.033% | 11.605% | - | - |
| Alkermes plc | -0.790% | 2.459% | 8.696% | -7.407% | 0.000% | -3.101% | 38.889% |
| Ironwood Pharmaceuticals | -5.380% | 7.653% | -33.016% | -50.059% | -58.627% | -61.982% | -45.351% |
| Arrowhead Pharmaceuticals Inc. | 0.730% | 7.427% | -16.554% | -15.983% | -21.413% | -58.166% | -20.180% |
Comments
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Barclays PLC from $355.00 to $350.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Truist Financial Co. from $367.00 to $383.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Robert W. Baird from $367.00 to $376.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
News
ICON Announces Appointment of New Chief Financial Officer
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO).
ICON Reports Second Quarter 2024 Results
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the second quarter ended June 30, 2024.
CEO, Dr
ICON announces results of Annual General Meeting and changes to the Board of Directors
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on